Published

Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Focus
Date: 2026-04-01
Source: Crossref
DOI: 10.1176/appi.focus.20250043
PubMed: 42538940

Authors

Meshkat Shakila Jha Manish K.Bhat Venkat

Watch author

Derived topics and classifications

psilocybin Mechanism of Action Other

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1007/bf02159243 10.1055/a-1721-2914 10.1038/npp.2017.84 10.1016/j.psychres.2020.112749 10.1016/s2215-0366(15)00576-3 10.1080/02791072.2017.1320734 10.1056/nejmoa2206443 10.1001/jama.2023.14530 10.1016/j.medj.2024.01.005 10.1016/s2215-0366(16)30065-7 10.1038/s41386-023-01648-7 10.1001/jamapsychiatry.2023.4685

Indexed papers citing this DOI

Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01

Related papers

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depressionJournal of Affective Disorders · 2026-11-01 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06 Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus.Hearing research · 2026-08-01 Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-09-01